X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Empowering consumers and improving access to out-of-pocket cost information

By Allyson Funk  |    June 16, 2016
A well-informed consumer is an engaged and empowered patient. One policy solution for delivering innovative treatments to patients is to engage and empower consumers by making more information...   Read More

CSRxP proposals would undermine competitive market, harm patients and innovation

By Robert Zirkelbach  |    April 25, 2016
These so-called market-based proposals are nothing more than a litany of new government regulations and mandates that would undermine the competitive market and empower government bureaucrats and...   Read More

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

By Holly Campbell  |    April 14, 2016
Despite misleading claims made about spending on new innovative treatments and cures, another report confirms how the competitive biopharmaceutical market works to control costs. Net prices for...   Read More

When coverage does not equal access to care

By Karyn Schwartz  |    February 19, 2016
Building on recent stories about the challenges even those with insurance are facing, new data show some consumers have no choice but to pay up to thousands of dollars out of pocket before their...   Read More

What they are saying: Rising deductibles and out-of-pocket costs in health insurance plans

By Allyson Funk  |    January 6, 2016
Many consumers are facing higher deductibles and cost sharing – including for services likes prescription medicines – that create barriers to accessing needed care. And a new Kaiser Family...   Read More

5 ways your insurer may prevent you from getting your medicine

By Allyson Funk  |    November 30, 2015
We’ve talked about the 5 things to consider when choosing your health coverage and the 5 questions to ask about your prescription medicine coverage, but it is also important to know the barriers...   Read More

Medicare Monday: Resources for understanding Medicare Part B and D

By Andrew Powaleny  |    September 7, 2015
Earlier this summer, PhRMA released its new chart pack on biopharmaceuticals in government programs. It serves as a great resource for key facts and figures about major government programs,...   Read More

Focusing on Only 1% of Spending Will Not Solve Nation’s Health Care Challenges

By Robert Zirkelbach  |    July 23, 2015
Commentary published today in Mayo Clinic Proceedings highlights a critical challenge facing cancer patients: the ability to access the medicines they need. But rather than address this issue...   Read More

Yet Another Misleading Report on Medicine Prices

By Robert Zirkelbach  |    May 13, 2015
Today Express Scripts released yet another misleading report to promote a false narrative about medicine spending in the United States.  For more than 50 years, spending on medicines has...   Read More

ICYMI: The New York Times Highlights How Increasing Cost Sharing Hinders Access, Raises Other Health Care Costs

By Allyson Funk  |    May 5, 2015
Yesterday, on The Upshot, Incidental Economist creator Austin Frakt explored the impact of high cost-sharing on consumers and other health care costs. He reiterates concerns we’ve been...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates